Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · IEX Real-Time Price · USD
3.090
-0.050 (-1.59%)
At close: May 17, 2024, 4:00 PM
3.080
-0.010 (-0.32%)
After-hours: May 17, 2024, 7:29 PM EDT
Taysha Gene Therapies Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for TSHA stock have an average target of 7.00, with a low estimate of 5.00 and a high estimate of 9.00. The average target predicts an increase of 126.54% from the current stock price of 3.09.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TSHA stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 4 | 4 | 3 | 3 | 4 | 4 |
| Hold | 4 | 4 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +126.54% | May 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +126.54% | May 15, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Initiates $2 → $8 | Hold → Strong Buy | Initiates | $2 → $8 | +158.90% | May 14, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +126.54% | May 2, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +126.54% | Apr 30, 2024 |
Financial Forecast
Revenue This Year
8.67M
from 15.45M
Decreased by -43.89%
Revenue Next Year
6.43M
from 8.67M
Decreased by -25.88%
EPS This Year
-0.41
from -0.96
EPS Next Year
-0.49
from -0.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 19.0M | 15.8M | 3.2M | 85.1M | 257.9M |
| Avg | 8.7M | 6.4M | 1.5M | 54.3M | 153.9M |
| Low | n/a | n/a | n/a | 27.4M | 54.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 23.0% | 81.7% | -51.0% | 5,459.4% | 375.0% |
| Avg | -43.9% | -25.9% | -76.2% | 3,449.1% | 183.4% |
| Low | - | - | - | 1,693.5% | 0.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.32 | -0.37 | -0.49 | -0.38 | -0.27 |
| Avg | -0.41 | -0.49 | -0.59 | -0.37 | -0.27 |
| Low | -0.56 | -0.62 | -0.67 | -0.35 | -0.25 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.